DFB Healthcare Acquisitions Corp.

Equities

AHCO

US23291E1091

Delayed Nasdaq 11:18:46 2021-10-05 am EDT 5-day change 1st Jan Change
23.49 USD -0.29% Intraday chart for DFB Healthcare Acquisitions Corp. -0.88% -37.27%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
AdaptHealth Names Suzanne Foster as CEO MT
UBS Adjusts AdaptHealth Price Target to $13 From $9, Maintains Buy Rating MT
Deutsche Bank Adjusts AdaptHealth Price Target to $10 From $8, Maintains Hold Rating MT
AdaptHealth's Q4 Loss Widens, Revenue Rises; Provides 2024 Revenue Guidance; Shares Climb MT
Earnings Flash (AHCO) ADAPTHEALTH Posts Q4 Revenue $858.2M, vs. Street Est of $825.5M MT
UBS Trims AdaptHealth Price Target to $9 From $10, Maintains Buy Rating MT
UBS Adjusts AdaptHealth Price Target to $10 From $18, Maintains Buy Rating MT
BofA Securities Downgrades AdaptHealth to Underperform From Neutral, Adjusts Price Target to $6.50 From $9.50 MT
AdaptHealth Facing Headwinds Due to Slower-Than-Expected Patient Transitions, BofA Says MT
Deutsche Bank Adjusts AdaptHealth Price Target to $8 From $14, Maintains Hold Rating MT
RBC Cuts Price Target on AdaptHealth to $13 From $18, Keeps Outperform Rating MT
Earnings Flash (AHCO) ADAPTHEALTH Reports Q3 Revenue $804M, vs. Street Est of $796.6M MT
BofA Securities Adjusts AdaptHealth's Price Target to $11 From $13, Keeps Neutral Rating MT
AdaptHealth Chief Executive Officer Steps Down MT
AdaptHealth's New CEO Gets Court Order Preventing Him From Assuming Role Until Oct. 15 MT
Sector Update: Health Care Stocks Slipping Late Afternoon MT
Sector Update: Health Care MT
AdaptHealth Shares Decline as Newly Appointed CEO Faces Lawsuit Over Alleged Trade-Secrets Concerns MT
Deutsche Bank Raises AdaptHealth Price Target to $14 From $11.30, Maintains Hold Rating MT
UBS Adjusts AdaptHealth Price Target to $18 From $15, Maintains Buy Rating MT
AdaptHealth's Q2 Earnings Flat, Revenue Rises; 2023 Revenue Guidance Tops Street View; Shares Rise MT
Earnings Flash (AHCO) ADAPTHEALTH Reports Q2 Revenue $793.3M, vs. Street Est of $765.2M MT
Alignment Healthcare Names Christopher Joyce Chief Legal and Administrative Officer MT
Baird Adjusts Price Target on AdaptHealth to $21 From $20, Maintains Outperform Rating MT
AdaptHealth Names Crispin Teufel Chief Executive MT
Chart DFB Healthcare Acquisitions Corp.
More charts
  1. Stock Market
  2. Equities
  3. AHCO Stock
  4. News DFB Healthcare Acquisitions Corp.
  5. UBS Adjusts Price Target on AdaptHealth to $40 From $44, Maintains Buy Rating